Drug Shortage Report for AVELOX

Last updated on 2019-07-05 History
Report ID 63973
Drug Identification Number 02242965
Brand name AVELOX
Common or Proper name Moxifloxacin
Company Name BAYER INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) MOXIFLOXACIN
Strength(s) 400MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30's
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-02-15
Actual start date
Estimated end date 2019-08-19
Actual end date 2019-07-04
Shortage status Resolved
Updated date 2019-07-05
Company comments Drug discontinued due to inability and no intent to meet demand.
Health Canada comments
Tier 3 Status No
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2019-07-05 English Compare
v18 2019-07-04 French Compare
v17 2019-07-04 French Compare
v16 2019-07-04 English Compare
v15 2019-04-11 French Compare
v14 2019-04-11 English Compare
v13 2019-03-13 French Compare
v12 2019-03-13 English Compare
v11 2019-02-16 English Compare
v10 2019-01-25 French Compare
v9 2019-01-25 English Compare
v8 2019-01-09 French Compare
v7 2019-01-09 English Compare
v6 2018-12-14 French Compare
v5 2018-12-14 English Compare
v4 2018-11-14 French Compare
v3 2018-11-14 English Compare
v2 2018-10-12 French Compare
v1 2018-10-12 English Compare

Showing 1 to 19 of 19